C WorldWide Group’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-625,123
Closed -$63.5M 98
2025
Q4
$63.5M Sell
625,123
-233,426
-27% -$18.7M 1.11% 19
2025
Q3
$47M Buy
858,549
+24,277
+3% +$1.21M 0.72% 21
2025
Q2
$44.3M Sell
834,272
-2,346
-0.3% -$119K 0.6% 23
2025
Q1
$36.2M Hold
836,618
0.45% 25
2024
Q4
$47M Sell
836,618
-664,211
-44% -$41.3M 0.57% 21
2024
Q3
$102M Sell
1,500,829
-3,526
-0.2% -$199K 1.06% 18
2024
Q2
$63.6M Buy
1,504,355
+366,385
+32% +$20.2M 0.69% 24
2024
Q1
$78.6M Buy
1,137,970
+505,797
+80% +$32M 0.9% 21
2023
Q4
$46.8M Hold
632,173
0.63% 21
2023
Q3
$43.1M Sell
632,173
-39,673
-6% -$3.37M 0.59% 20
2023
Q2
$63.1M Sell
671,846
-16,552
-2% -$1.29M 0.81% 18
2023
Q1
$46.7M Buy
688,398
+69,706
+11% +$4.48M 0.64% 18
2022
Q4
$30.6M Sell
618,692
-202
-0% -$8.25K 0.41% 23
2022
Q3
$20.1M Buy
618,894
+170,000
+38% +$7.01M 0.28% 30
2022
Q2
$17.7M Buy
448,894
+108,689
+32% +$5.81M 0.22% 32
2022
Q1
$23.8M Buy
340,205
+7,864
+2% +$575K 0.26% 30
2021
Q4
$25.9M Buy
332,341
+68,889
+26% +$6.08M 0.24% 29
2021
Q3
$25.1M Buy
263,452
+911
+0.3% +$96.2K 0.26% 27
2021
Q2
$32.6M Buy
262,541
+5,677
+2% +$678K 0.34% 24
2021
Q1
$33.9M Sell
256,864
-30,000
-10% -$4.11M 0.33% 28
2020
Q4
$38M Sell
286,864
-95,000
-25% -$11.5M 0.38% 22
2020
Q3
$38.9M Buy
381,864
+92,234
+32% +$7.97M 0.44% 21
2020
Q2
$25.2M Sell
289,630
-45,000
-13% -$3.6M 0.29% 27
2020
Q1
$19.4M Buy
334,630
+155,698
+87% +$12.6M 0.27% 29
2019
Q4
$16.5M Hold
178,932
0.2% 36
2019
Q3
$16.2M Hold
178,932
0.21% 31
2019
Q2
$21.1M Buy
178,932
+120,000
+204% +$12.1M 0.26% 28
2019
Q1
$5.11M Sell
58,932
-9,399
-14% -$800K 0.06% 55
2018
Q4
$4.31M Sell
68,331
-24,241
-26% -$1.66M 0.06% 52
2018
Q3
$7.31M Sell
92,572
-20,127
-18% -$1.31M 0.09% 51
2018
Q2
$6.74M Buy
112,699
+24,006
+27% +$1.29M 0.09% 52
2018
Q1
$3.58M Buy
88,693
+15,383
+21% +$750K 0.05% 63
2017
Q4
$3.85M Sell
73,310
-79,820
-52% -$4.26M 0.06% 68
2017
Q3
$7.21M Sell
153,130
-9,580
-6% -$386K 0.1% 53
2017
Q2
$5.75M Sell
162,710
-28,444
-15% -$878K 0.09% 57
2017
Q1
$4.51M Buy
191,154
+16,154
+9% +$320K 0.08% 58
2016
Q4
$2.34M Sell
175,000
-75,000
-30% -$1.21M 0.05% 77
2016
Q3
$4.64M Hold
250,000
0.08% 55
2016
Q2
$3.06M Hold
250,000
0.06% 60
2016
Q1
$1.69M Hold
250,000
0.03% 77
2015
Q4
$2.31M Hold
250,000
0.04% 76
2015
Q3
$4.5M Buy
250,000
+30,000
+14% +$689K 0.08% 56
2015
Q2
$6.54M Hold
220,000
0.09% 52
2015
Q1
$4.84M Buy
+220,000
New +$5.58M 0.07% 58

Other funds holding EXAS

C WorldWide Group's EXAS Position: Q1 2026 in Review

C WorldWide Group sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 625,123 shares — an estimated $63.5M sold.

C WorldWide Group first reported a position in EXAS in Q1 2015 and held it in 44 quarters. The position peaked at $102M in Q3 2024. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • C WorldWide Group reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • C WorldWide Group sold 625,123 Exact Sciences shares in Q1 2026, an estimated $63.5M.
  • C WorldWide Group first reported a position in Exact Sciences in Q1 2015 and held it in 44 quarters.
  • C WorldWide Group's Exact Sciences position peaked at $102M in Q3 2024.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on C WorldWide Group's 13F filing for Q1 2026, filed 6 May 2026.